marketcap
Facebook
X
TelegramGW Pharmaceuticals plc Total Liabilities 2011-2025 | GWPH
Annual Total Liabilities GW Pharmaceuticals plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 198 M | 156 M | 75.4 M | 73.3 M | 71.3 M | 67.4 M | 56.7 M | 38.1 M | 35 M | 33.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 198 M | 33.5 M | 80.5 M |
Total Liabilities of other stocks in the Drug manufacturers industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Evolus
EOLS
|
227 M | $ 6.49 | 1.49 % | $ 402 M |  USA |
 |
Amryt Pharma plc
AMYT
|
459 M | $ 14.7 | - | $ 621 M |  Britain |
 |
Aerie Pharmaceuticals
AERI
|
449 M | $ 15.25 | - | $ 754 M | USA |
 |
PetIQ
PETQ
|
478 M | $ 13.6 | 1.64 % | $ 400 M | USA |
 |
Agile Therapeutics
AGRX
|
26.6 M | $ 0.6 | 10.11 % | $ 58.2 M | USA |
 |
Teligent, Inc.
TLGT
|
198 M | $ 0.173 | -13.85 % | $ 16.1 M | USA |
 |
Recro Pharma
REPH
|
94.8 M | $ 1.4 | -4.76 % | $ 65.3 M | USA |
 |
Athenex
ATNX
|
228 M | $ 0.2 | -23.39 % | $ 1.76 M | USA |
 |
PLx Pharma
PLXP
|
25 M | $ 0.09 | -27.8 % | $ 2.56 M | USA |
 |
Shineco, Inc.
TYHT
|
13.8 M | $ 11.09 | -3.90 % | $ 97.2 M |  China |
 |
Lannett Company
LCI
|
735 M | $ 0.66 | 1.15 % | $ 7.11 M | USA |
 |
Organogenesis Holdings
ORGO
|
113 M | $ 3.87 | -3.25 % | $ 510 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
250 M | $ 40.0 | -0.1 % | $ 2.03 B |  Schweden |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
170 M | $ 8.22 | - | $ 376 M | USA |
 |
Perrigo Company plc
PRGO
|
5.33 B | $ 20.31 | -1.12 % | $ 2.79 B | USA |
 |
ProPhase Labs
PRPH
|
24 M | $ 0.29 | -9.29 % | $ 4.6 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
92.4 B | $ 13.49 | 0.6 % | $ 2.24 B |  India |
 |
Flexion Therapeutics, Inc.
FLXN
|
269 M | $ 9.12 | - | $ 459 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
20 M | $ 4.5 | 1.35 % | $ 17.8 M | China |
 |
Kindred Biosciences, Inc.
KIN
|
28.3 M | $ 9.25 | 0.11 % | $ 419 M | USA |
 |
Sanofi
SNY
|
51.4 B | $ 49.28 | -1.54 % | $ 66.8 B |  France |
 |
Neos Therapeutics, Inc.
NEOS
|
97 M | $ 1.15 | -2.54 % | $ 57.2 M | USA |
 |
Endo International plc
ENDP
|
10.3 B | $ 0.29 | - | $ 28.9 M |  Irlanda |
 |
Supernus Pharmaceuticals
SUPN
|
332 M | $ 56.69 | 1.77 % | $ 3.12 B | USA |
 |
Tricida
TCDA
|
168 M | $ 0.11 | - | $ 3.25 M | USA |
 |
China SXT Pharmaceuticals
SXTC
|
6.22 M | $ 1.41 | 0.01 % | $ 2.01 M | China |
 |
PPD, Inc.
PPD
|
7.04 B | $ 47.25 | 0.13 % | $ 16.6 B | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
33.6 B | $ 20.41 | -0.54 % | $ 23.1 B |  Israel |
 |
Tilray
TLRY
|
977 M | $ 1.24 | -5.34 % | $ 766 M |  Canada |
 |
Bausch Health Companies
BHC
|
27.4 B | $ 6.79 | -0.44 % | $ 2.48 B | Canada |
 |
HEXO Corp.
HEXO
|
367 M | $ 0.71 | 2.45 % | $ 38.1 M | - |
 |
Veru
VERU
|
28.1 M | $ 2.56 | -1.54 % | $ 345 M | USA |
 |
Neptune Wellness Solutions
NEPT
|
25.1 M | $ 0.2 | -45.3 % | $ 917 K | Canada |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
465 M | $ 42.97 | - | $ 1.62 B | Israel |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
2.25 B | $ 116.3 | - | $ 26.6 B | Irlanda |
 |
Viatris
VTRS
|
28.9 B | $ 10.54 | 0.05 % | $ 12.8 B | USA |
 |
FSD Pharma
HUGE
|
7.87 M | $ 5.84 | 5743.5 % | $ 69.7 M | Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
11.6 M | $ 0.78 | 0.86 % | $ 117 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
9.29 M | $ 1.3 | - | $ 55.5 M | USA |
 |
Guardion Health Sciences
GHSI
|
8.52 M | $ 3.25 | -0.31 % | $ 3.64 M | USA |
 |
Aurora Cannabis
ACB
|
244 M | $ 4.57 | -6.35 % | $ 86.3 M | - |
 |
Alimera Sciences
ALIM
|
107 M | $ 5.54 | - | $ 142 M | USA |
 |
Biogen
BIIB
|
11.3 B | $ 150.51 | -0.61 % | $ 21.9 B | USA |
|
Qilian International Holding Group Limited
QLI
|
18.7 M | $ 5.41 | -6.08 % | $ 184 M | China |
 |
Amneal Pharmaceuticals
AMRX
|
3.32 B | $ 5.91 | 2.6 % | $ 892 M | - |
 |
Ironwood Pharmaceuticals
IRWD
|
496 M | $ 1.87 | 0.55 % | $ 297 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
90.4 M | $ 18.93 | 0.08 % | $ 1.8 B | France |
 |
Cumberland Pharmaceuticals
CPIX
|
53 M | $ 2.7 | -2.17 % | $ 38 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
173 M | $ 2.14 | -39.89 % | $ 27.7 M | USA |